Back to AVBP

UBS Group AG → AVBP

UBS Group AG AVBP Position History

ArriVent BioPharma, Inc. • Healthcare

Quarters held
7
Latest value
$198K
Q3 2026
Peak value
$16.2M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$9.2M
Q4 2025$9.1M
Q4 2025$7K
Q1 2026$11.2M
Q2 2026$15.2M
Q3 2026$16.2M
Q3 2026$198K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$198K6.5K——
Q3 2026$16.2M535.0K——
Q2 2026$15.2M438.6K——
Q1 2026$11.2M486.3K——
Q4 2025$7K333——
Q4 2025$9.1M450.6K——
Q3 2025$9.2M497.6K——

Other funds holding AVBP

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B